ISSN: 2155-9899
+44 1223 790975
Frank Weichold
Director, Science and Innovation, OCS, OC at FDA
Dr. Weichold is leading teams in Clinical Pharmacology, DMPK, as a Director at MedImmune LLC, Gaithersburg, MD. Prior, he directed research and clinical development of vaccines at the Aeras Foundation. As a tenured Professor at Morgan State University, he developed and managed independent research programs and trained MS and PhD students. He held a faculty position at the University of Maryland Biotechnology Institute to study signal transduction pathways that affect immune responses. During five years of postdoctoral education, Dr. Weichold worked at the National Institutes of Health in Bethesda, Maryland, first at the LTCB (NCI) where he researched immune pathologies in HIV infection, then at the Hematology Branch of the NHLBI where bone marrow transplantation immunology was the focus of his studies. Dr. Weichold is an Adjunct Professor at MSU, and holds a M.D., and a Ph.D. in Immunology from the Humboldt University in Berlin, Germany.
Cell Biology, Biotechnology, Virology, Microbiology, Immunology, Infectious Diseases